PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 22, 2023Inflammatory Bowel Diseases45 citationsOpen Access

Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease

View Full Paper
ESElizabeth A. SpencerSBSuzannah BergsteinMDMichael T. Dolinger

Key Points

Key points are not available for this paper at this time.

Abstract

While awaiting pediatric registration trials, our data suggest that UPA is effective in inducing and maintaining SF-CR in adolescents with highly-refractory IBD with an acceptable safety profile.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Spencer et al. (2023) studied this question.

synapsesocial.com/papers/69d896568c03fbaff8bef8cbhttps://doi.org/10.1093/ibd/izad300
Ask AI
Helpful
Bookmark
Share
View Full Paper